Promising Clinical Trial Results for Drug for Rare Disease in Which Patients Can’t Eat Fat
Health & BehaviorIn a Phase III clinical trial, the drug volanesorsen significantly reduced blood fat (triglyceride) levels in participants with a rare disease called familial chylomicronemia syndrome; finding could also help inform better prevention methods and treatments for many types of heart disease.